HMI Medical Unveils New Brand Identities Across Its Healthcare Facilities in Malaysia As Regional Cross-border Healthcare Grows
The refreshed identities of HMI Medical's hospitals and medical centre in Malaysia signal the Group's commitment to deliver more with care by sparking change for the future of healthcare SINGAPORE and KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- HMI Medical is strengthening its regional healthcare network by introducing refreshed brand...
NTL HEALTHCARE Launches On-Premises AI Solution ‘CerviCARE® AI AT’ Globally
Supports Local AI Analysis and Data Management, Retains Core CerviCARE® AI Features, and Adds DICOM File Generation SEONGNAM, South Korea, Oct. 15, 2026 /PRNewswire/ -- NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-powered cervical screening system, CerviCARE® AI. CerviCARE® AI AT CerviCARE® AI uses...
Opella: New study demonstrates successful cough treatment extends beyond symptom relief
PARIS, Oct. 15, 2026 /PRNewswire/ -- A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient's overall well-being, alongside traditional symptomatic relief. With most consumers1 making treatment...
Tsingke Customer Quality Audit Highlights Manufacturing Systems and Quality Controls
BEIJING, Oct. 14, 2026 /PRNewswire/ -- As synthetic biology expands into new applications, standardized manufacturing processes, reliable production data, and robust quality management systems are becoming increasingly important. Tsingke recently hosted an on-site customer quality audit conducted by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. at its Chengdu manufacturing facility. The audit focused on four key areas: raw material traceability,...
Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026
Receives Awards for MedTech Innovation and AI-Driven Clinical Development; Only Korean Company Recognized in Two Categories Recognized for its capabilities in AI-driven clinical support and ICL services, with plans to expand partnerships with global CROs SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and...
Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study
AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study published in Nature Medicine, in which its AI-powered pathology platform, Lunit SCOPE, identified...
Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention
Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 study BRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company developing precision...
MIRACELL to Host Stem Cell Science Day 2026 in Los Angeles, Featuring International Clinical Insights in Regenerative Medicine
- Leading South Korean and U.S. medical experts to share clinical insights into regenerative medicine - Austrian clinical study on 47 ACL rupture patients treated with SMART M-CELL published in peer-reviewed journal LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Miracell U.S. Inc., the U.S. subsidiary of South Korean stem cell technology pioneer Miracell, will host "Stem Cell Science...
Prof. Gang Shen Named Among World’s Top 2% Scientists for Fourth Consecutive Year
SHANGHAI, Oct. 14, 2026 /PRNewswire/ -- Prof. Gang Shen of Taikang ByBo Dental has been named among the World's Top 2% Scientists for the fourth consecutive year, according to the ninth edition of the database jointly released by Stanford University and Elsevier. Prof. Shen has been recognised on the Single-Year Scientific Impact list in 2023, 2024, 2025 and...
NueCell Bio Joins CIRM’s Industry Resource Partner Program to Support California’s Stem Cell and Gene Therapy Innovators
SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced today it has joined the Industry Resource Partnership (IRP) Program of the California Institute for Regenerative Medicine (CIRM), a state agency. The designation, formalized through a...
